skip to Main Content

GAN DIO-MASH model is top-ranked by the LITMUS consortium

Gubra’s GAN DIO-MASH mouse model has been top-ranked by the LITMUS¹ consortium for its human proximity score. The LITMUS consortium has evaluated a wide variety of preclinical MASH models using two key parameters, metabolic significance and ability to induce fibrosis. In…

Read more

Gubra strengthens Board of Directors

Gubra, a leader in preclinical services within metabolic and fibrotic diseases and with a strong pipeline of novel discovery projects, today announced the election of Monika Lessl and Astrid Haug as new independent members of the Board of Directors as…

Read more

Gubra – Extraordinary general meeting

Today, at 10:00 CET, Gubra A/S (“Gubra”) held an extraordinary general meeting at Plesner Advokatpartnerselskab, Amerika Plads 37, DK-2100 Copenhagen. All proposals presented to the general meeting were adopted:Item 1Election of Monika Leesl and Astrid Haug as new members to the…

Read more
Back To Top